Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Dal Ferro

Showing results (81-90 of 93) with videos related to

Pageof 10
Sort By:
Circulation|September 30, 2021
Phenotypic Expression, Natural History, and Risk Stratification of Cardiomyopathy Caused by Filamin C Truncating VariantsMarta Gigli, Davide Stolfo, Sharon L Graw, et al.
Cardiovascular Research|May 5, 2020
Towards standardization of echocardiography for the evaluation of left ventricular function in adult rodents: a position paper of the ESC Working Group on Myocardial FunctionSerena Zacchigna, Alessia Paldino, Inês Falcão-Pires, et al.
JACC. Heart Failure|July 18, 2025
Genetic and Phenotypic Characterization of Nexilin (NEXN)-Related Cardiomyopathy: Results From a Multicentric StudyMaria Perotto, Alessia Paldino, Francesco Mazzarotto, et al.
European Heart Journal|June 29, 2022
Importance of genotype for risk stratification in arrhythmogenic right ventricular cardiomyopathy using the 2019 ARVC risk calculatorAlexandros Protonotarios, Riccardo Bariani, Chiara Cappelletto, et al.
Journal of the American College of Cardiology|December 3, 2016
Truncating FLNC Mutations Are Associated With High-Risk Dilated and Arrhythmogenic CardiomyopathiesMartín F Ortiz-Genga, Sofía Cuenca, Matteo Dal Ferro, et al.
Journal of the American College of Cardiology|September 15, 2022
Clinical Risk Score to Predict Pathogenic Genotypes in Patients With Dilated CardiomyopathyLuis Escobar-Lopez, Juan Pablo Ochoa, Ana Royuela, et al.
Circulation. Heart Failure|September 24, 2025
Sex Differences in Prognosis of Patients With Genetic Dilated CardiomyopathySophie L V M Stroeks, Marco Merlo, Nerea Mora-Ayestaran, et al.
Medrxiv : the Preprint Server for Health Sciences|August 8, 2025
The contribution of <i>RBM20</i> truncating variants to human cardiomyopathyBrendan J Floyd, Joyce N Njoroge, Vikki A Krysov, et al.
JAMA Cardiology|April 8, 2026
RBM20 Truncating Variants and Human CardiomyopathyBrendan J Floyd, Joyce N Njoroge, Vikki A Krysov, et al.
Circulation. Genomic and Precision Medicine|July 8, 2026
Variant Site-Specific Natural History of Titin-Induced Cardiomyopathy: An International Multicenter RegistryMaria Perotto, Cinzia Radesich, Alessia Paldino, et al.
Pageof 10

Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
Circulation|September 30, 2021
Phenotypic Expression, Natural History, and Risk Stratification of Cardiomyopathy Caused by Filamin C Truncating VariantsMarta Gigli, Davide Stolfo, Sharon L Graw, et al.
Cardiovascular Research|May 5, 2020
Towards standardization of echocardiography for the evaluation of left ventricular function in adult rodents: a position paper of the ESC Working Group on Myocardial FunctionSerena Zacchigna, Alessia Paldino, Inês Falcão-Pires, et al.
JACC. Heart Failure|July 18, 2025
Genetic and Phenotypic Characterization of Nexilin (NEXN)-Related Cardiomyopathy: Results From a Multicentric StudyMaria Perotto, Alessia Paldino, Francesco Mazzarotto, et al.
European Heart Journal|June 29, 2022
Importance of genotype for risk stratification in arrhythmogenic right ventricular cardiomyopathy using the 2019 ARVC risk calculatorAlexandros Protonotarios, Riccardo Bariani, Chiara Cappelletto, et al.
Journal of the American College of Cardiology|December 3, 2016
Truncating FLNC Mutations Are Associated With High-Risk Dilated and Arrhythmogenic CardiomyopathiesMartín F Ortiz-Genga, Sofía Cuenca, Matteo Dal Ferro, et al.
Journal of the American College of Cardiology|September 15, 2022
Clinical Risk Score to Predict Pathogenic Genotypes in Patients With Dilated CardiomyopathyLuis Escobar-Lopez, Juan Pablo Ochoa, Ana Royuela, et al.
Circulation. Heart Failure|September 24, 2025
Sex Differences in Prognosis of Patients With Genetic Dilated CardiomyopathySophie L V M Stroeks, Marco Merlo, Nerea Mora-Ayestaran, et al.
Medrxiv : the Preprint Server for Health Sciences|August 8, 2025
The contribution of <i>RBM20</i> truncating variants to human cardiomyopathyBrendan J Floyd, Joyce N Njoroge, Vikki A Krysov, et al.
JAMA Cardiology|April 8, 2026
RBM20 Truncating Variants and Human CardiomyopathyBrendan J Floyd, Joyce N Njoroge, Vikki A Krysov, et al.
Circulation. Genomic and Precision Medicine|July 8, 2026
Variant Site-Specific Natural History of Titin-Induced Cardiomyopathy: An International Multicenter RegistryMaria Perotto, Cinzia Radesich, Alessia Paldino, et al.
Pageof 10